From the Journals

Psoriasis patients often have history of childhood trauma


 

FROM THE JOURNAL OF PSYCHOSOMATIC RESEARCH

Psoriasis patients showed a greater prevalence of childhood trauma and less resilience than persons without psoriasis, reported Maria Luigia Crosta, of Catholic University of the Sacred Heart, Rome, and her associates.

©Rodd100/thinkstockphotos.com
In a study of 77 psoriasis patients aged 18-65 years and 76 controls from the general population, the psoriasis patients scored significantly higher on childhood trauma than the controls on the Childhood Trauma Questionnaire-Short Form total scores, as well as scoring higher on sexual abuse, emotional neglect, and physical neglect subscales. Patients with psoriasis also had lower scores than the controls on the Connor-Davidson Resilience scale. There was no correlation between Childhood Trauma Questionnaire-Short Form and Connor-Davidson Resilience scale scores and clinical aspects of psoriasis such as Psoriasis Area and Severity Index scores, age of onset, or duration of illness.

“Improving resilience with a multidisciplinary approach and an early psychological intervention could facilitate the management of psoriasis, by promoting the establishment of a stronger therapeutic alliance and a better acceptance of disease. Programs for psoriasis patients should focus on self-motivation and strengthening of self-efficacy,” Dr. Crosta and her associates concluded.

SOURCE: Crosta ML et al. J Psychosom Res. 2018;106:25-8.

Recommended Reading

Pushing the Limits: Developing a New Standard of Care for Psoriasis
MDedge Dermatology
Emerging Therapies In Psoriasis: A Systematic Review
MDedge Dermatology
Current Guidelines for Psoriasis Treatment: A Work in Progress
MDedge Dermatology
Biologics and Systemic Therapies for Psoriasis: Treat the Patient, Not the Disease
MDedge Dermatology
Pediatric Psoriasis: An Interview With Nanette B. Silverberg, MD
MDedge Dermatology
Xeljanz: FDA panel recommends ulcerative colitis indication
MDedge Dermatology
Study highlights need to investigate psoriasis treatment outcomes in skin of color patients
MDedge Dermatology
PASI responses with biologics similar among white, nonwhite individuals, study finds
MDedge Dermatology
FDA approves IL-23 antagonist for plaque psoriasis
MDedge Dermatology
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Dermatology